Detalhe da pesquisa
1.
Two Phase 3 Trials of Baricitinib for Alopecia Areata.
N Engl J Med
; 386(18): 1687-1699, 2022 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35334197
2.
Predicting disease genes based on multi-head attention fusion.
BMC Bioinformatics
; 24(1): 162, 2023 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37085750
3.
Matching within a hybrid RCT/RWD: framework on associated causal estimands.
J Biopharm Stat
; 33(4): 439-451, 2023 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35929973
4.
Power priors with entropy balancing weights in data augmentation of partially controlled randomized trials.
J Biopharm Stat
; 32(1): 4-20, 2022 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35072583
5.
Prediction and risk stratification from hospital discharge records based on Hierarchical sLDA.
BMC Med Inform Decis Mak
; 22(1): 14, 2022 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35033059
6.
Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study.
J Am Acad Dermatol
; 85(4): 847-853, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34090959
7.
The inverse-probability-of-censoring weighting (IPCW) adjusted win ratio statistic: an unbiased estimator in the presence of independent censoring.
J Biopharm Stat
; 30(5): 882-899, 2020 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32552451
8.
Regression analysis of mixed panel count data with dependent terminal events.
Stat Med
; 36(10): 1669-1680, 2017 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28098397
9.
Mechanosensing of cells in 3D gel matrices based on natural and synthetic materials.
Cell Biol Int
; 38(11): 1233-43, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24919784
10.
Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review.
Dermatol Ther (Heidelb)
; 13(12): 2951-2991, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37833617
11.
Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata: A Pooled Analysis of the BRAVE-AA1 and BRAVE-AA2 Trials.
JAMA Dermatol
; 159(9): 970-976, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37556146
12.
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2).
Am J Clin Dermatol
; 24(3): 443-451, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36855020
13.
An Additive-Multiplicative Mean Model for Panel Count Data with Dependent Observation and Dropout Processes.
Scand Stat Theory Appl
; 46(2): 414-431, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31223184
14.
Regression analysis of incomplete data from event history studies with the proportional rates model.
Stat Interface
; 11(1): 91-97, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29276554